{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:42:52Z","timestamp":1790476972756,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003761","name":"University Medical Centre Utrecht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.phro.2025.100792","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T02:38:49Z","timestamp":1749091129000},"page":"100792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["FAPI-positron emission tomography for radiotherapy in head and neck cancer: applications and future directions"],"prefix":"10.1016","volume":"35","author":[{"given":"Mischa","family":"de Ridder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"de Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"de Keizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2025.100792_b0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2009.07.1708","article-title":"Parotid gland function after radiotherapy: the combined michigan and utrecht experience","volume":"78","author":"Dijkema","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2025.100792_b0010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.radonc.2016.01.019","article-title":"Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy","volume":"118","author":"Head","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100792_b0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2022.10.034","article-title":"Post-radiation primary hypothyroidism in patients with head and neck cancer: external validation of thyroid gland dose-volume constraints with long-term endocrine outcomes","volume":"177","author":"Chow","year":"2022","journal-title":"Radiother Oncol"},{"issue":"08","key":"10.1016\/j.phro.2025.100792_b0020","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/cancers14081909","article-title":"MR-guided adaptive radiotherapy for OAR sparing in head and neck cancers","volume":"14","author":"Mulder","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phro.2025.100792_b0025","article-title":"Individual elective lymph node irradiation for the reduction of complications in head and neck cancer patients (iNode): a phase-I feasibility trial protocol","volume":"39","author":"Reinders","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.phro.2025.100792_b0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.radonc.2020.07.056","article-title":"First experience with model-based selection of head and neck cancer patients for proton therapy","volume":"151","author":"Tambas","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100792_b0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.radonc.2022.01.013","article-title":"The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: significant acute and late toxicity reduction","volume":"168","author":"Al-Mamgani","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100792_b0040","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00405-019-05340-9","article-title":"FDG-PET\/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation","volume":"276","author":"de Ridder","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.phro.2025.100792_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gregoire","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100792_b0050","doi-asserted-by":"crossref","first-page":"e7192","DOI":"10.1002\/cam4.7192","article-title":"Adaptive radiotherapy for head and neck cancer: pitfalls and possibilities from the radiation oncologist's point of view","volume":"13","author":"Nuyts","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.phro.2025.100792_b0055","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","article-title":"Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Machiels","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.phro.2025.100792_b0060","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2967\/jnumed.122.263902","article-title":"(18)F-FDG PET\/CT staging of head and neck cancer: interobserver agreement and accuracy-results from multicenter ACRIN 6685 clinical trial","volume":"63","author":"Subramaniam","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.phro.2025.100792_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110182","article-title":"Improved delineation with diffusion weighted imaging for laryngeal and hypopharyngeal tumors validated with pathology","volume":"194","author":"Smits","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100792_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16101905","article-title":"Role of (18)F-FDG PET\/CT in head and neck squamous cell carcinoma: current evidence and innovative applications","volume":"16","author":"Caldarella","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phro.2025.100792_b0075","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00259-011-1893-y","article-title":"Diagnostic performance of post-treatment FDG PET or FDG PET\/CT imaging in head and neck cancer: a systematic review and meta-analysis","volume":"38","author":"Gupta","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.phro.2025.100792_b0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-019-0362-2","article-title":"Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities","volume":"17","author":"Wang","year":"2019","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.phro.2025.100792_b0085","doi-asserted-by":"crossref","first-page":"36505","DOI":"10.1074\/jbc.274.51.36505","article-title":"Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts","volume":"274","author":"Park","year":"1999","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.phro.2025.100792_b0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2967\/jnumed.124.269002","article-title":"SNMMI procedure standard\/EANM practice guideline for fibroblast activation protein (FAP) PET","volume":"66","author":"Hope","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.phro.2025.100792_b0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40644-024-00699-3","article-title":"Head-to-head comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG PET\/CT for the evaluation of tonsil cancer and lymph node metastases: a single-centre retrospective study","volume":"24","author":"Ji","year":"2024","journal-title":"Cancer Imaging"},{"issue":"9","key":"10.1016\/j.phro.2025.100792_b0100","first-page":"1821","article-title":"Head-to-head comparison of FDG and radiolabeled FAPI PET: a systematic review of the literature","volume":"13","author":"Guglielmo","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.phro.2025.100792_b0105","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s11307-022-01749-7","article-title":"Head-to-head comparison of [(68)Ga]Ga-FAPI-46-PET\/CT and [(18)F]F-FDG-PET\/CT for radiotherapy planning in head and neck cancer","volume":"24","author":"Wegen","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.phro.2025.100792_b0110","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2967\/jnumed.120.253062","article-title":"Impact of (68)Ga-FAPI PET\/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas","volume":"62","author":"Rohrich","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.phro.2025.100792_b0115","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/RLU.0000000000005610","article-title":"Dual-time point 68 ga-FAPI-04 PET\/CT improves tumor delineation and cervical lymph node metastasis identification in patients with head and neck squamous cell carcinoma","volume":"50","author":"Jiang","year":"2025","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.phro.2025.100792_b0120","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1007\/s00259-023-06138-y","article-title":"The performance of (68)Ga-FAPI-04 PET\/CT in head and neck squamous cell carcinoma: a prospective comparison with (18)F-FDG PET\/CT","volume":"50","author":"Jiang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.phro.2025.100792_b0125","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2967\/jnumed.121.262790","article-title":"The added value of (68)Ga-FAPI PET\/CT in patients with head and neck cancer of unknown primary with (18)F-FDG-negative findings","volume":"63","author":"Gu","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.phro.2025.100792_b0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2967\/jnumed.123.266556","article-title":"Imaging of tumor stroma using (68)Ga-FAPI PET\/CT to improve diagnostic accuracy of primary tumors in head and neck cancer of unknown primary: a comparative imaging trial","volume":"65","author":"Gu","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.phro.2025.100792_b0135","first-page":"44","article-title":"Diagnostic value of (18)F-FDG and (68)Ga-FAPI in head and neck cancers: a systematic review and meta-analysis","volume":"28","author":"Ma","year":"2025","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.phro.2025.100792_b0140","article-title":"Comparison of (18)F-fluorodeoxyglucose PET and (68)Ga-fibroblast activation protein inhibitor PET in head and neck cancers: a systematic review and meta-analysis","volume":"10","author":"Huang","year":"2025","journal-title":"Acad Radiol"},{"key":"10.1016\/j.phro.2025.100792_b0145","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","author":"Loktev","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.phro.2025.100792_b0150","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1007\/s00259-020-04859-y","article-title":"Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers","volume":"47","author":"Syed","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.phro.2025.100792_b0155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2021.04.016","article-title":"(68)Ga-FAPI-PET\/CT improves diagnostic staging and radiotherapy planning of adenoid cystic carcinomas \u2013 imaging analysis and histological validation","volume":"160","author":"R\u00f6hrich","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100792_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110838","article-title":"A systematic review and proportional meta-analysis of image-based pattern of loco-regional failure analyses outcomes in head and neck squamous cell carcinoma","volume":"207","author":"Kristensen","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2025.100792_b0165","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1007\/s00259-020-04818-7","article-title":"[(68)Ga]Ga-DOTA-FAPI-04 improves tumor staging and monitors early response to chemoradiotherapy in a patient with esophageal cancer","volume":"47","author":"Zhao","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.phro.2025.100792_b0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/0194599815621742","article-title":"Detecting residual\/recurrent head neck squamous cell carcinomas using PET or PET\/CT: systematic review and meta-analysis","volume":"154","author":"Cheung","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.phro.2025.100792_b0175","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.clon.2018.09.007","article-title":"Use of diffusion-weighted imaging and (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the response assessment for (chemo)radiotherapy in head and neck squamous cell carcinoma","volume":"30","author":"Noij","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.phro.2025.100792_b0180","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2214\/AJR.20.23841","article-title":"Best practices: application of NI-RADS for posttreatment surveillance imaging of head and neck cancer","volume":"216","author":"Strauss","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.phro.2025.100792_b0185","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4103\/njms.njms_57_24","article-title":"NIRADS-based case assessment of post-treatment head and neck cancer and its clinical correlation: a validation study","volume":"15","author":"Mishra","year":"2024","journal-title":"Natl J Maxillofac Surg"},{"key":"10.1016\/j.phro.2025.100792_b0190","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy","volume":"12","author":"Liu","year":"2019","journal-title":"J Hematol Oncol"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631625000971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631625000971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T01:16:18Z","timestamp":1757726178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631625000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":38,"alternative-id":["S2405631625000971"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2025.100792","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FAPI-positron emission tomography for radiotherapy in head and neck cancer: applications and future directions","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2025.100792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100792"}}